This is the sixth drug in a row that has received certification from the organization in terms of safety and effectiveness.
The World Health Organization (WHO) has recommended a vaccine from the Chinese company Sinopharm for emergency use against the coronavirus. The Director-General of the World Health Organization (WHO) Tedros Adanom Ghebreyesus stated this on Friday at a briefing in Geneva.
“Today, WHO has included the Beijing Sinopharm vaccine in the list of medicines recommended for emergency use against COVID-19, which is the sixth vaccine to be certified by WHO for safety, efficacy, and quality,” he said.
As explained by the head of the WHO, this step has expanded the list of drugs for immunization against covid, which can be purchased through the international mechanism COVAX. In addition, the approval process for the Sinopharm vaccine by the regulatory authorities of the States can be accelerated, and this will allow them to purchase and use it.
In turn, Mariangela Simao, Assistant Director-General of the organization, explained that the inclusion of the Sinopharm vaccine in the list of WHO-recommended emergency medicines for coronavirus creates opportunities to “accelerate access to vaccines for countries that want to protect health workers and populations at risk.” “We encourage the manufacturer [Sinopharm] to participate in the COVAX mechanism and contribute to achieving a more equal distribution of vaccines,” Simao said.